Revanesse Versa costs less than its main competitors primarily because of market positioning, not because it’s an inferior product. The manufacturer, Prollenium Medical Technologies, entered the U.S. market later than established brands and priced Versa aggressively to win market share from Juvederm and Restylane. At the wholesale level, Versa syringes run as low as $175 to $210 each, while Juvederm and Restylane wholesale prices typically sit higher. That difference flows through to what you pay in the treatment chair, where Versa often costs $100 to $200 less per syringe than premium-branded alternatives.
Market Position Drives the Price Gap
Allergan (Juvederm) and Galderma (Restylane) have dominated the U.S. filler market for over a decade. They spend heavily on direct-to-consumer advertising, loyalty programs like Allē and Aspire, and extensive sales networks. Those costs are baked into the price of every syringe. Prollenium, a Canadian company, entered the U.S. market more recently and without that same brand recognition. Pricing Versa lower was a deliberate strategy to get injectors to try a new product and build a patient base from scratch.
This is a common pattern in medical aesthetics. When a newer competitor offers a comparable product, it needs a reason for providers to switch from what they already know and trust. A lower wholesale price gives clinics better margins, which either translates into savings for patients or higher profit per treatment for the practice. Either way, providers have a financial incentive to stock Versa alongside or instead of pricier options.
The Formulation Is Comparable
Versa is made from the same core ingredient as Juvederm and Restylane: hyaluronic acid, a sugar molecule naturally found in your skin. Versa’s concentration sits at 22 to 28 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine for comfort during injection. That concentration range is in line with what you’d find in competing mid-range fillers designed for nasolabial folds and similar facial wrinkles.
The cross-linking technology (which determines how firm the gel is and how long it lasts) differs between brands, but these are engineering variations rather than quality differences. Each brand uses its own proprietary process to link hyaluronic acid molecules together into a gel that holds its shape under the skin. Versa uses a process that produces a smooth, uniform gel, which many injectors report causes less swelling in the first 24 to 48 hours compared to some competitors. That said, individual responses vary.
Each Versa syringe contains 1.2 mL of product, slightly more than the standard 1.0 mL syringe offered by most Juvederm and Restylane products. That extra volume, small as it sounds, means you’re getting about 20% more filler per syringe, which further stretches the cost advantage.
FDA Approval and Clinical Testing
Versa went through the same FDA premarket approval process required of all dermal fillers sold in the United States. It’s approved for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults 22 and older. A newer version, Versa Lips+, carries approval for lip augmentation as well. The clinical trials supporting these approvals ran for 8 to 10 months, and FDA documents note that many patients maintained correction at six months.
That six-month mark is broadly consistent with what patients experience with similar Juvederm and Restylane products in the same treatment areas. Some people see results lasting longer, others shorter, depending on their metabolism, the treatment area, and the amount injected. The lower price doesn’t come with a meaningful trade-off in how long results last.
What You Actually Save
At the patient level, a syringe of Versa typically runs between $350 and $500, depending on your geographic area and the provider’s markup. A comparable syringe of Juvederm Ultra or Restylane-L generally falls between $500 and $700. If your treatment plan calls for two syringes, you could save $200 to $400 by choosing Versa over a premium-branded alternative.
Keep in mind that the provider’s skill matters far more than the brand name on the syringe. An experienced injector using Versa will deliver better results than a less skilled one using the most expensive filler on the market. The hyaluronic acid gel is a tool. The artistry is in placement, depth, and volume decisions.
Why Some Providers Don’t Carry It
Despite the price advantage, not every clinic stocks Versa. Some providers have longstanding relationships with Allergan or Galderma that include volume discounts, training programs, and marketing support. Switching brands means retraining staff, adjusting to a slightly different gel consistency, and potentially losing loyalty program perks that patients have come to expect. Providers who have dialed in their technique with one product over many years may not see enough reason to change, even if the wholesale cost is lower.
Other providers embrace Versa specifically because the lower cost lets them offer competitive pricing without cutting into their margins. If you’re interested in trying it, look for an injector who has worked with Versa regularly and can show before-and-after results from their own patients. The savings are real, but choosing a provider with experience in the specific product matters more than the price difference.